NCT07011706Phase 2Active not recruiting

ATI-045 Versus Placebo in Patients With Moderate-to-Severe Atopic Dermatitis

Study sponsor: Aclaris Therapeutics, Inc. · ACRS

Primary completion is the date data collection ends for the main study measures, not when results are published.

Primary completion2026-09-21Actual
Enrollment · participants110Actual
Source updated2026-09-29Last update listed in the registry record

Changes to this trial

Last 12 months
Filters
Clear filters

· 2 fields changed

Completion date type changed

Before: Estimated. After: Actual.

Primary completion date changed

Before: Aug 2026. After: 21 Sep 2026.

Check registry source

· 3 fields changed

Participant count type changed

Before: Estimated. After: Actual.

Enrollment · participant count changed

Before: 96 participants (planned). After: 110 participants (actual).

Recruitment status changed

Before: Recruiting. After: Active not recruiting.

Check registry source